Panacela Labs – biotechnology company developing gene therapy innovative drug “Mobilan” for prostate cancer therapy.

News

The Ministry of Industry and Trade

The Ministry of Industry and Trade of RF approved Panacela Labs report developed in accordance with State Contract “Transfer of foreign development of immunotherapy drug product based on the viral vector containing genes of TL receptor and its agonist for treatment of prostate cancer and conduct of its preclinical and clinical studies”.

nominated

Mobilan is nominated for Galien Award-2016 in nomination “The best research in Russia”. International award Prix Galien – the recognition of technological and scientific research advances necessary for development of innovative drug products.

Involvement of immune system in fight with tumor cells is one of the most modern and prospective approaches to cancer therapy Vasily Kazey СЕО Panacela Labs LLC